239 related articles for article (PubMed ID: 23365656)
1. Screening of a specific peptide binding to VPAC1 receptor from a phage display peptide library.
Tang B; Li Z; Huang D; Zheng L; Li Q
PLoS One; 2013; 8(1):e54264. PubMed ID: 23365656
[TBL] [Abstract][Full Text] [Related]
2. Generation of PEGylated VPAC1-selective antagonists that inhibit proliferation of a lung cancer cell line.
Pan CQ; Hamren S; Roczniak S; Tom I; DeRome M
Peptides; 2008 Mar; 29(3):479-86. PubMed ID: 17942192
[TBL] [Abstract][Full Text] [Related]
3. Spatial approximation between the C-terminus of VIP and the N-terminal ectodomain of the VPAC1 receptor.
Ceraudo E; Tan YV; Couvineau A; Lacapere JJ; Laburthe M
Ann N Y Acad Sci; 2006 Jul; 1070():180-4. PubMed ID: 16888162
[TBL] [Abstract][Full Text] [Related]
4. Expression and localization of VPAC1, the major receptor of vasoactive intestinal peptide along the length of the intestine.
Jayawardena D; Guzman G; Gill RK; Alrefai WA; Onyuksel H; Dudeja PK
Am J Physiol Gastrointest Liver Physiol; 2017 Jul; 313(1):G16-G25. PubMed ID: 28385693
[TBL] [Abstract][Full Text] [Related]
5. Photoaffinity labeling demonstrates physical contact between vasoactive intestinal peptide and the N-terminal ectodomain of the human VPAC1 receptor.
Tan YV; Couvineau A; Van Rampelbergh J; Laburthe M
J Biol Chem; 2003 Sep; 278(38):36531-6. PubMed ID: 12807902
[TBL] [Abstract][Full Text] [Related]
6. Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction.
Ceraudo E; Hierso R; Tan YV; Murail S; Rouyer-Fessard C; Nicole P; Robert JC; Jamin N; Neumann JM; Robberecht P; Laburthe M; Couvineau A
FASEB J; 2012 May; 26(5):2060-71. PubMed ID: 22291440
[TBL] [Abstract][Full Text] [Related]
7. [Screening peptides binding specifically to large intestinal cancer LoVo cells from phage random peptide library].
Liao KX; Yao XQ; Wu CT; Lin F; Wu WL; Zeng SD; Luo YQ; Lei ST
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):986-90. PubMed ID: 18583245
[TBL] [Abstract][Full Text] [Related]
8. Ac His1 [D-Phe2, K15, R16, L27] VIP (3-7)/GRF (8-27)--a VPAC1 receptor antagonist--is an inverse agonist on two constitutively active truncated VPAC1 receptors.
Vertongen P; Langlet C; Langer I; Gaspard N; Robberecht P
Peptides; 2004 Nov; 25(11):1943-9. PubMed ID: 15501526
[TBL] [Abstract][Full Text] [Related]
9. Diffuse pharmacophoric domains of vasoactive intestinal peptide (VIP) and further insights into the interaction of VIP with the N-terminal ectodomain of human VPAC1 receptor by photoaffinity labeling with [Bpa6]-VIP.
Tan YV; Couvineau A; Laburthe M
J Biol Chem; 2004 Sep; 279(37):38889-94. PubMed ID: 15247290
[TBL] [Abstract][Full Text] [Related]
10. The vasoactive intestinal peptide (VIP) alpha-Helix up to C terminus interacts with the N-terminal ectodomain of the human VIP/Pituitary adenylate cyclase-activating peptide 1 receptor: photoaffinity, molecular modeling, and dynamics.
Ceraudo E; Murail S; Tan YV; Lacapère JJ; Neumann JM; Couvineau A; Laburthe M
Mol Endocrinol; 2008 Jan; 22(1):147-55. PubMed ID: 17885205
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the new photoaffinity probe (Bz2-K24)-VIP.
Tan YV; Couvineau A; Lacapere JJ; Laburthe M
Ann N Y Acad Sci; 2006 Jul; 1070():575-80. PubMed ID: 16888228
[TBL] [Abstract][Full Text] [Related]
12. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
[TBL] [Abstract][Full Text] [Related]
13. Serine 447 in the carboxyl tail of human VPAC1 receptor is crucial for agonist-induced desensitization but not internalization of the receptor.
Marie JC; Rouyer-Fessard C; Couvineau A; Nicole P; Devaud H; El Benna J; Laburthe M
Mol Pharmacol; 2003 Dec; 64(6):1565-74. PubMed ID: 14645688
[TBL] [Abstract][Full Text] [Related]
14. Screening and identification of a novel hepatocellular carcinoma cell binding peptide by using a phage display library.
Zhu X; Wu H; Luo S; Xianyu Z; Zhu D
J Huazhong Univ Sci Technolog Med Sci; 2008 Jun; 28(3):299-303. PubMed ID: 18563328
[TBL] [Abstract][Full Text] [Related]
15. Selection of CC chemokine receptor 5-binding peptide from a phage display peptide library.
Wang FY; Zhang TY; Luo JX; He GA; Gu QL; Xiao F
Biosci Biotechnol Biochem; 2006 Sep; 70(9):2035-41. PubMed ID: 16960395
[TBL] [Abstract][Full Text] [Related]
16. Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.
Nachtergael I; Gaspard N; Langlet C; Robberecht P; Langer I
Cell Signal; 2006 Dec; 18(12):2121-30. PubMed ID: 16650965
[TBL] [Abstract][Full Text] [Related]
17. Selection and characterization of colorectal cancer cell-specific peptides.
Wang H; Ma C; Li R; Guo Y; He Y; Wang X; Chen Y; Hou Y
Biotechnol Lett; 2013 May; 35(5):671-7. PubMed ID: 23338703
[TBL] [Abstract][Full Text] [Related]
18. Presence of a N-terminal signal peptide in class II G protein-coupled receptors: crucial role for expression of the human VPAC1 receptor.
Couvineau A; Rouyer-Fessard C; Laburthe M
Regul Pept; 2004 Dec; 123(1-3):181-5. PubMed ID: 15518910
[TBL] [Abstract][Full Text] [Related]
19. The role of vasoactive intestinal peptide (VIP) in megakaryocyte proliferation.
Nam C; Case AJ; Hostager BS; O'Dorisio MS
J Mol Neurosci; 2009 Feb; 37(2):160-7. PubMed ID: 18663606
[TBL] [Abstract][Full Text] [Related]
20. Contribution of the carboxyl terminus of the VPAC1 receptor to agonist-induced receptor phosphorylation, internalization, and recycling.
Langlet C; Langer I; Vertongen P; Gaspard N; Vanderwinden JM; Robberecht P
J Biol Chem; 2005 Jul; 280(30):28034-43. PubMed ID: 15932876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
